Experience

Hopewell Pharma Ventures

• United States
• Pharmaceutical Manufacturing
• 1 - 100 Employee

• President & CEO

  • May 2020 - Present

  Co-founder and senior executive of a Company focused on the development of high-value generic and 505b2 products. Co-founder and senior executive of a Company focused on the development of high-value generic and 505b2 products.



Amerigen Pharmaceuticals

• United States
• Pharmaceutical Manufacturing
• 1 - 100 Employee

• Chief Business Officer

  • Jan 2011 - Apr 2020

  Reporting to the CEO, and working out of the Company's global HQ in Lyndhurst NJ, the role was to lead a team of business development and sales professionals to manage all the commercial activities for an emerging generic pharmaceutical business with a focus on the U.S. and China markets. Responsibilities included product selection & portfolio management, corporate & business development, licensing, commercial contracting, management of patent litigation and settlements, plus sales & distribution of generic pharmaceuticals in the target markets. The role concluded with the successful sale of the Company's entire U.S. product portfolio of 23 ANDA's to ANI Pharmaceuticals, Inc. in early 2020. Show less



Catalent Pharma Solutions

• United States
• Pharmaceutical Manufacturing
• 700 & Above Employee

• VP Product Ventures

  • Apr 2007 - Dec 2010

  Reporting to the CEO, and working out of the Company's global HQ in Somerset NJ, the role was to lead a department of dedicated professionals in a new business venture to develop products based on the company's pharmaceutical technologies in strategic partnerships with generic and branded pharmaceutical companies. Responsible for managing activities including product selection, business development & licensing and all aspects of product development. This resulted in the filing of 16 ANDA's, including 6 sole first-to-files. Show less



Cardinal Health

• United States
• Hospitals and Health Care
• 700 & Above Employee

• VP Business Development

  • Oct 2005 - Apr 2007

  Based in the U.S. and responsible for the identification and evaluation of business opportunities pertaining to branded and generic product development / acquisition and related deal negotiations

• VP Business Development (Europe)

  • Dec 2000 - Sep 2005

  Responsible for European commerical operations in the Pharmaceutical Technologies and Services segment of Cardinal Health



R.P Scherer

• European Strategic Development Director

  • Sep 1999 - Nov 2000

  Working out of the Company's European HQ in Zug, Switzerland, responsible for evaluating and executing strategic projects under the direction of the company's European President. Working out of the Company's European HQ in Zug, Switzerland, responsible for evaluating and executing strategic projects under the direction of the company's European President.



R.P. Scherer

• New Technologies Manager

  • Oct 1995 - Aug 1999

  Working out of the company's operations in Swindon, and subsequently Clydebank, in the UK; responsible for the evaluation and development of new drug delivery technologies and related products in the oral fast dissolve, oral controlled release, ophthalmic and inhalation areas.

• Senior Scientist / Section Head Formulation

  • Apr 1992 - Sep 1995

  Working out of the company's operations in Swindon, UK; responsible for formulation R&D and project management